Argus Investors Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Sell |
4,784
-40
| -0.8% | -$31.2K | 2.65% | 7 |
|
|
2025
Q1 | $3.98M | Sell |
4,824
-424
| -8% | -$350K | 3.04% | 4 |
|
|
2024
Q4 | $4.05M | Sell |
5,248
-26
| -0.5% | -$20.1K | 2.71% | 5 |
|
|
2024
Q3 | $4.67M | Sell |
5,274
-2,999
| -36% | -$2.66M | 3.05% | 4 |
|
|
2024
Q2 | $7.49M | Buy |
8,273
+692
| +9% | +$627K | 4.6% | 2 |
|
|
2024
Q1 | $5.9M | Buy |
7,581
+740
| +11% | +$576K | 3.62% | 2 |
|
|
2023
Q4 | $3.99M | Sell |
6,841
-927
| -12% | -$540K | 2.56% | 6 |
|
|
2023
Q3 | $4.17M | Buy |
7,768
+60
| +0.8% | +$32.2K | 3.01% | 4 |
|
|
2023
Q2 | $3.62M | Sell |
7,708
-971
| -11% | -$455K | 2.51% | 4 |
|
|
2023
Q1 | $2.98M | Sell |
8,679
-56
| -0.6% | -$19.2K | 2.26% | 5 |
|
|
2022
Q4 | $3.2M | Sell |
8,735
-134
| -2% | -$49K | 2.56% | 4 |
|
|
2022
Q3 | $2.87M | Sell |
8,869
-575
| -6% | -$186K | 2.55% | 3 |
|
|
2022
Q2 | $3.06M | Buy |
9,444
+135
| +1% | +$43.8K | 2.26% | 3 |
|
|
2022
Q1 | $2.67M | Buy |
9,309
+874
| +10% | +$250K | 1.7% | 14 |
|
|
2021
Q4 | $2.33M | Buy |
8,435
+804
| +11% | +$222K | 1.4% | 24 |
|
|
2021
Q3 | $1.76M | Buy |
7,631
+594
| +8% | +$137K | 1.15% | 50 |
|
|
2021
Q2 | $1.62M | Buy |
7,037
+741
| +12% | +$170K | 0.66% | 51 |
|
|
2021
Q1 | $1.18M | Buy |
6,296
+709
| +13% | +$132K | 0.48% | 52 |
|
|
2020
Q4 | $943K | Buy |
5,587
+580
| +12% | +$97.9K | 0.41% | 56 |
|
|
2020
Q3 | $741K | Buy |
+5,007
| New | +$741K | 0.31% | 61 |
|